- Home
- ISPR vs STRO Comparison
ISPR vs STRO Comparison
Compare ISPR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- STRO
- Stock Information
- Founded
- ISPR 2010
- STRO 2003
- Country
- ISPR United States
- STRO United States
- Employees
- ISPR N/A
- STRO N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ISPR Health Care
- STRO Health Care
- Exchange
- ISPR Nasdaq
- STRO Nasdaq
- Market Cap
- ISPR 91.6M
- STRO 94.9M
- IPO Year
- ISPR 2023
- STRO 2018
- Fundamental
- Price
- ISPR $2.17
- STRO $0.84
- Analyst Decision
- ISPR Strong Buy
- STRO Hold
- Analyst Count
- ISPR 1
- STRO 7
- Target Price
- ISPR $7.50
- STRO $1.97
- AVG Volume (30 Days)
- ISPR 50.3K
- STRO 807.6K
- Earning Date
- ISPR 11-06-2025
- STRO 11-06-2025
- Dividend Yield
- ISPR N/A
- STRO N/A
- EPS Growth
- ISPR N/A
- STRO N/A
- EPS
- ISPR N/A
- STRO N/A
- Revenue
- ISPR $118,506,875.00
- STRO $105,646,000.00
- Revenue This Year
- ISPR $60.96
- STRO $65.48
- Revenue Next Year
- ISPR $23.96
- STRO N/A
- P/E Ratio
- ISPR N/A
- STRO N/A
- Revenue Growth
- ISPR N/A
- STRO N/A
- 52 Week Low
- ISPR $1.44
- STRO $0.52
- 52 Week High
- ISPR $6.56
- STRO $3.01
- Technical
- Relative Strength Index (RSI)
- ISPR 56.45
- STRO 43.15
- Support Level
- ISPR $1.85
- STRO $0.84
- Resistance Level
- ISPR $1.99
- STRO $0.95
- Average True Range (ATR)
- ISPR 0.23
- STRO 0.08
- MACD
- ISPR 0.07
- STRO -0.01
- Stochastic Oscillator
- ISPR 89.13
- STRO 19.44
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.